Endothelial dysfunction in breast cancer survivors on aromatase inhibitors (AIs) over time

被引：0
|
作者：
Blaes, A. H. [1 ]
Petersen, A. [1 ]
Beckwith, H. [1 ]
Potter, D. [1 ]
Florea, N. [1 ]
Yee, D. [1 ]
Vogel, R. [1 ]
Duprez, D. [1 ]
机构：
[1] Univ Minnesota, Minneapolis, MN USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS18-P1-12-06
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-12-06
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Endothelial dysfunction in breast cancer survivors on aromatase inhibitors: changes over time
    Shaaban, Adnan
    Petersen, Ashley
    Beckwith, Heather
    Florea, Natalia
    Potter, David A.
    Yee, Douglas
    Vogel, Rachel I.
    Duprez, Daniel
    Blaes, Anne H.
    [J]. CARDIO-ONCOLOGY, 2024, 10 (01)
  • [2] Longitudinal follow-up of endothelial function in breast cancer survivors on aromatase inhibitors (AIs).
    Blaes, Anne Hudson
    Beckwith, Heather Christine
    Hebbel, Robert P.
    Solovey, Anna S.
    Potter, David
    Yee, Douglas
    Petersen, Ashley
    Vogel, Rachel Isaksson
    Luepker, Russell V.
    Duprez, Daniel
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [3] Psychological measures of stress and biomarkers of inflammation, aging, and endothelial dysfunction in breast cancer survivors on aromatase inhibitors
    Blaes, Anne H.
    Nair, Chandini
    Everson-Rose, Susan
    Jewett, Patricia
    Wolf, Jack
    Zordoky, Beshay
    [J]. SCIENTIFIC REPORTS, 2023, 13 (01)
  • [4] Psychological measures of stress and biomarkers of inflammation, aging, and endothelial dysfunction in breast cancer survivors on aromatase inhibitors
    Anne H. Blaes
    Chandini Nair
    Susan Everson-Rose
    Patricia Jewett
    Jack Wolf
    Beshay Zordoky
    [J]. Scientific Reports, 13
  • [5] PHARMACOGENETICS OF AROMATASE INHIBITORS (AIS) IN PATIENTS WITH METASTATIC BREAST CANCER
    Ferraldeschi, R.
    Arnedos, M.
    Hadfield, K.
    Ahern, R.
    Drury, S.
    Roberts, S.
    Howell, A.
    Smith, I.
    Newman, W.
    Dowsett, M.
    [J]. ANNALS OF ONCOLOGY, 2011, 22 : 60 - 60
  • [6] Aromatase inhibitors, arthralgias, and exercise in breast cancer survivors
    Irwin, Melinda
    Cartmel, Brenda
    Ercolano, Elizabeth
    Fiellin, Martha
    Rothbard, Marianna
    Capozza, Scott
    Zhou, Yang
    Schmitz, Kathryn
    Ligibel, Jennifer A.
    Hershman, Dawn L.
    Neogi, Tuhina
    Gross, Cary P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [7] Aromatase inhibitors, tamoxifen, and endometrial cancer in breast cancer survivors
    Chlebowski, Rowan T.
    Schottinger, Joanne E.
    Shi, Jiaxiao
    Chung, Joanie
    Haque, Reina
    [J]. CANCER, 2015, 121 (13) : 2147 - 2155
  • [8] Sexual Dysfunction and Aromatase Inhibitor Use in Survivors of Breast Cancer
    Kwan, Karen W.
    Chlebowski, Rowan T.
    [J]. CLINICAL BREAST CANCER, 2009, 9 (04) : 219 - 224
  • [9] Managing Aromatase Inhibitors in Breast Cancer Survivors: Not Just for Oncologists
    Files, Julia A.
    Ko, Marcia G.
    Pruthi, Sandhya
    [J]. MAYO CLINIC PROCEEDINGS, 2010, 85 (06) : 560 - 566
  • [10] Aromatase inhibitors and breast cancer: time for a change?
    Fentiman, IS
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2004, 58 (12) : 1152 - 1158
12345